| Azilva (azilsartan) / Takeda |
ChiCTR2300073602: Study on the effect and transformation of Azilsartan on improving microcirculation in hypertension |
|
|
| Not yet recruiting | 4 | 60 | | Daily oral administration of Azilsartan tablets 20mg ;lifestyle intervention | The First Affiliated Hospital of Sun Yat-sen University; The First Affiliated Hospital of Sun Yat-sen University, Suzhou Industrial Park Xinxin Cardiovascular Health Foundation | Hypertension | | | | |
ChiCTR2300069585: The use of Azilsartan in patients with post-operation of radiofrequency ablation in AF |
|
|
| Not yet recruiting | 4 | 240 | | Oral Azilsartan ;Oral Candestan ;N/A | Shanxi Provincial Hospital of Cardiovascular Diseases; Shanxi Provincial Hospital of Cardiovascular Diseases, Constant Heart Hypertension / Cardiorenal Protection Medical Research Foundation | Atrial fibrillation | | | | |
ChiCTR2300071431: Study on the efficacy and mechanism of ARB drugs in patients with coronary microcirculation disorders after PCI surgery for coronary heart disease |
|
|
| Not yet recruiting | 4 | 120 | | Conventional drug therapy + Azilsartan 20mg qd ;Conventional drug therapy | Shaanxi Provincial People’s Hospital; Shaanxi Provincial People’s Hospital, Self-raised | Coronary heart disease PCI surgery with coronary microcirculation disorders | | | | |
ChiCTR2300071464: An observational study of a new generation of ARB drug, azilsartan, in elderly patients with hypertension and sarcopenia |
|
|
| Not yet recruiting | 4 | 150 | | Azisartan 20mg qd ;Azisartan 20mg qd | Sir Run Run Hospital, Nanjing Medical University; Sir Run Run Hospital, Nanjing Medical University, Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Hypertension | | | | |
AZAF, NCT05841654: Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension |
|
|
| Not yet recruiting | 4 | 400 | RoW | Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI | Beijing Tsinghua Chang Gung Hospital | Hypertension, Atrial Fibrillation | 06/25 | 10/25 | | |
ChiCTR2300076082: A single-center randomized crossover controlled trial to evaluate the efficacy and safety of azisartan in the treatment of proteinuria and renal function in non-dialytic hypertensive patients with IgA nephropathy |
|
|
| Not yet recruiting | 4 | 302 | | The first 12 weeks after taking azilsartan to valsartan; After taking valsartan in the first 12 weeks, it was changed to azilsartan. | Chinese Cardiovascular Association-HX Fund; Department of Nephrology, The Third Affiliated hospital of Southern Medical university, Guangzhou, China., Chinese Cardiovascular Association-HX Fund | IgA nephropathy | | | | |
ChiCTR2300073598: Comparison of the effects of sacubitril/valsartan and azilsartan on left ventricular remodeling in hypertensive patients with elevated angiopoietin-like 7 based on two-dimensional speckle-tracking echocardiography |
|
|
| Not yet recruiting | 4 | 60 | | Shakubaqu valsartan 200mg/dose, once daily; Azilsartan 20mg/dose, once daily | The First People's Hospital of Lianyungang; The First People's Hospital of Lianyungang, The Lianyungang Health Commission and The First People's Hospital of Lianyungang | hypertension | | | | |
